PCV40 COST-EFFECTIVENESS ANALYSIS OF PRASUGREL, CLOPIDOGREL AND TICAGRELOR IN DUAL ANTIPLATELET THERAPY ON PATIENTS WITH ACUTE CORONARY SYNDROME IN AUSTRIA BETWEEN 2009 AND 2014
Autor: | Marchev, S., Sheikh Rezaei, S., Geroldinger, A., Heinze, G., Reichardt, B., Wolzt, M. |
---|---|
Zdroj: | In Value in Health May 2020 23 Supplement 1:S97-S97 |
Databáze: | ScienceDirect |
Externí odkaz: |